Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and Adults by RETAIN, Aurélie, KATTYGNARATH, Darouna, AZARD, Julie, CHATELUT, Etienne, DELBALDO, Catherine, GEOERGER, Birgit, BARROIS, Michel, SERONIE-VIVIEN, Sophie, LECESNE, Axel, VASSAL, Gilles

Get full text

Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients by Berton, Dominique, Floquet, Anne, Lescaut, Willy, Baron, Gabriel, Kaminsky, Marie-Christine, Toussaint, Philippe, Largillier, Rémy, Savoye, Aude-Marie, Alexandre, Jérôme, Delbaldo, Catherine, Malaurie, Emmanuelle, Barletta, Hugues, Bosacki, Claire, Garnier-Tixidre, Claire, Follana, Philippe, Laharie-Mineur, Hortense, Briac Levache, Charles, Valenza, Bruno, Dechartres, Agnès, Mollon-Grange, Delphine, Selle, Frédéric

Get full text

Pharmacokinetic-Pharmacodynamic Relationships of Imatinib and Its Main Metabolite in Patients with Advanced Gastrointestinal Stromal Tumors by DELBALDO, Catherine, CHATELUT, Etienne, RE, Micheline, DEROUSSENT, Alain, SERONIE-VIVIEN, Sophie, JAMBU, Aurore, BERTHAUD, Patrice, LE CESNE, Axel, BLAY, Jean-Yves, VASSAL, Gilles

Get full text

Sunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potential by Delbaldo, Catherine, Faivre, Sandrine, Dreyer, Chantal, Raymond, Eric

Request full text

Predictive biomarkers for the activity of mammalian target of rapamycin (mTOR) inhibitors by Delbaldo, Catherine, Albert, Sébastien, Dreyer, Chantal, Sablin, Marie-Paule, Serova, Maria, Raymond, Eric, Faivre, Sandrine

Get full text

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised... by Bidard, François-Clément, Hardy-Bessard, Anne-Claire, Dalenc, Florence, Bachelot, Thomas, Pierga, Jean-Yves, de la Motte Rouge, Thibault, Sabatier, Renaud, Dubot, Coraline, Ferrero, Jean Marc, Ladoire, Sylvain, Levy, Christelle, Mouret-Reynier, Marie-Ange, Lortholary, Alain, Grenier, Julien, Chakiba, Camille, Stefani, Laetitia, Plaza, Jérôme Edouard, Clatot, Florian, Teixeira, Luis, D'Hondt, Véronique, Vegas, Hélène, Derbel, Olfa, Garnier-Tixidre, Claire, Canon, Jean-Luc, Pistilli, Barbara, André, Fabrice, Bièche, Ivan, Callens, Céline, Lemonnier, Jérôme, Delaloge, Suzette, PISTILLI, Barbara, DALENC, Florence, BACHELOT, Thomas, SABATIER, Renaud, DUBOT, Coraline, FRENEL, Jean-Sébastien, FERRERO, Jean-Marc, LADOIRE, Sylvain, LEVY, Christelle, MOURET-REYNIER, Marie-Ange, HARDY-BESSARD, Anne-Claire, LORTHOLARY, Alain, GRENIER, Julien, CHAKIBA, Camille, STEFANI, Laetitia, SOULIE, Patrick, PLAZA, Jérôme Edouard, CLATOT, Florian, TEIXEIRA, Luis, D'HONDT, Véronique, VEGAS, Hélène, DERBEL, Olfa, GARNIER TIXIDRE, Claire, CHENEAU, Caroline, PAITEL, Jean-François, BERNARD-MARTY, Chantal, SPAETH, Dominique, MOULLET, Isabelle, DEIANA, Laura, GREILSAMER, Charlotte, VENAT-BOUVET, Laurence, DELECROIX, Valérie, MELIS, Adrien, ORFEUVRE, Hubert, NGUYEN, Suzanne, LEGOUFFE, Eric, ZANNETTI, Alain, LE SCODAN, Romuald, DOHOLLOU, Nadine, DALIVOUST, Philippe, ARSENE, Olivier, MARQUES, Nathalie, PETIT, Thierry, MOLLON, Delphine, DAUBA, Jérôme, BONNIN, Nathalie, GARDNER, Miriam, MARTI, Adina, LEVACHE, Charles-Briac, LACHAIER, Emma, ACHILLE, Mihaela, VALMAR, Christophe, BOUAITA, Ryan, MEDIONI, Jacques, FOA, Cyril, DEL PIANO, Francesco, GOZY, Michel, ESCANDE, Anne, LEDUC, Nicolas, LUCAS, Brigitte, AMMARGUELLAT, Hanifa, NAJEM, Abeer, TROUBOUL, Fanny, DESCLOS, Hervé, MAYEUR, Didier, LORCHEL, Fabrice, BOUDRANT, Axelle, GISSEROT, Olivier, ALLEAUME, Corinne, DE GRAMONT, Aimery

Get full text

Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials by Bradley, Rosie, Gray, Richard, Hills, Robert K, Pan, Hongchao, Peto, Richard, Dodwell, David, McGale, Paul, Taylor, Carolyn, Chen, Xiaosong, Ejlertsen, Bent, Friedl, Thomas W P, Janni, Wolfgang, Nitz, Ulrike, Norton, Larry, Robert, Nicholas, Slamon, Dennis, Sparano, Joseph, Watanabe, Toru, Boddington, Clare, Clarke, Mike, Davies, Christina, Godwin, Jon, Lui, Hui, McHugh, Theresa, Morris, Philip, Read, Simon, Straiton, Ewan, Hunt, Kelly K, Delbaldo, Catherine, Piedbois, Pascal, Fesl, Christian, Gnant, Michael, Eikesdal, Hans Petter, Lønning, Per Eystein, Bee, Valerie, Martin, Miguel, Regan, Meredith, Di Leo, Angelo, Bartlett, John, Chen, Bingshu E, Levine, Mark N, Parulekar, Wendy, Shepherd, Lois, Berry, Donald, Shulman, Lawrence N, Winer, Eric, Shapiro, Charles L, Christiansen, Peer, Mouridsen, Henning T, Van Rossum, Annelot G J, Van Tinteren, Harm, Van Werkhoven, Erik, Gray, Robert, Bogaerts, Jan, Poncet, Coralie, Huovinen, Riikka, Carrasco, Eva M, Loibl, Sibylle, Nekljudova, Valentina, Thomssen, Christoph, Kümmel, Sherko, Saloustros, Emmanouil, Michiels, Stefan, Mathoulin-Pelissier, Simone, Sarmento, Roberta M B, Rossi, Anna, Bliss, Judith, Kilburn, Lucy, Masuda, Norikazu, Toi, Masakazu, Foroglou, Pericles, Kondylis, D, Reinisch, Mattea, Lee, Keun Seok, Ro, Jung Sil, Hiller, Louise, De Mastro, Lucia, Venturini, Macro, Delozier, Thierry, Lemonnier, Jerome, Martin, Anne-Laure, Hayes, Dan, Ellis, Paul, Hsu, Limin, Eremin, Oleg, Ahlgren, Johan, Blomqvist, Carl, Lindman, Henrik, Bergsten-Nordström, Elizabeth, Carey, Lisa, Dignam, James, Francis, Prudence A, Goetz, Matthew P, Jagsi, Reshma, Pierce, Lori, Rutgers, Emiel, Salgado, Roberto, Tutt, Andrew, Whelan, Tim, Cameron, David

Get full text

Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer: A Meta-analysis by Paoletti, Xavier, Oba, Koji, Burzykowski, Tomasz, Michiels, Stefan, Ohashi, Yasuo, Pignon, Jean-Pierre, Rougier, Philippe, Sakamoto, Junichi, Sargent, Daniel, Sasako, Mitsuru, Van Cutsem, Eric, Buyse, Marc

Get full text

Phase I evaluation of seliciclib ( R -roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies by Le Tourneau, Christophe, Faivre, Sandrine, Laurence, Valérie, Delbaldo, Catherine, Vera, Karina, Girre, Veronique, Chiao, Judy, Armour, Sian, Frame, Sheelagh, Green, Simon R, Gianella-Borradori, Athos, Diéras, Veronique, Raymond, Eric

Get full text

Benefits of Adding a Drug to a Single-Agent or a 2-Agent Chemotherapy Regimen in Advanced Non–Small-Cell Lung Cancer: A Meta-analysis by Delbaldo, Catherine, Michiels, Stefan, Syz, Nathalie, Soria, Jean-Charles, Le Chevalier, Thierry, Pignon, Jean-Pierre

Get full text

Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis by Oba, Koji, Paoletti, Xavier, Bang, Yung-Jue, Bleiberg, Harry, Burzykowski, Tomasz, Fuse, Nozomu, Michiels, Stefan, Morita, Satoshi, Ohashi, Yasuo, Pignon, Jean-Pierre, Rougier, Philippe, Sakamoto, Junichi, Sargent, Daniel, Sasako, Mitsuru, Shitara, Kohei, Tsuburaya, Akira, Van Cutsem, Eric, Buyse, Marc

Get full text

Abstract PD9-08: Prognostic value of EndoPredict test in patients screened for UNIRAD, a UCBG randomized, double blind, phase III international trial evaluating the addition of eve... by Penault-Llorca, Frederique, Dalenc, Florence, Chabaud, Sylvie, Cottu, Paul, Allouache, Djelila, Cameron, David, Jacquin, Jean-Philippe, Grenier, Julien, Bouvet, Laurence Venat, Jegannathen, Apurna, Campone, Mario, Piano, Francesco Del, Debled, Marc, Hardy-Bessard, Anne-Claire, Giacchetti, Sylvie, Barthelemy, Philippe, Kaluzinski, Laure, Mailliez, Audrey, Mouret-Reynier, Marie-Ange, Legouffe, Eric, Cayre, Anne, Martinez, Mathilde, Delbaldo, Catherine, Mollon-Grange, Delphine, Macaskill, E. Jane, Sephton, Matthew, Stefani, Laëtitia, Belgadi, Blaha, Winter, Matthew, Orfeuvre, Hubert, Lacroix-Triki, Magali, Bonnefoi, Herve, Bliss, Judith, Canon, Jean-Luc, Lemonnier, Jerome, Andre, Fabrice, Bachelot, Thomas

Get full text

Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors by Delbaldo, Catherine, Raymond, Eric, Vera, Karina, Hammershaimb, Luz, Kaucic, Karen, Lozahic, Stéphanie, Marty, Michel, Faivre, Sandrine

Get full text

Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial by Romeo, Clémence, Joly, Florence, Ray-Coquard, Isabelle, El Kouri, Claude, Mercier-Blas, Anne, Berton-Rigaud, Dominique, Kalbacher, Elsa, Cojocarasu, Oana, Fabbro, Michel, Cretin, Jacques, Zannetti, Alain, Abadie-Lacourtoisie, Sophie, Mollon, Delphine, Hardy-Bessard, Anne-Claire, Provansal, Magali, Blot, Emmanuel, Delbaldo, Catherine, Lesoin, Anne, Freyer, Gilles, You, Benoît

Get full text

Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 –... by Aparicio, Thomas, Darut-Jouve, Ariane, Khemissa Akouz, Faiza, Montérymard, Carole, Artru, Pascal, Cany, Laurent, Romano, Olivier, Valenza, Bruno, Le Foll, Christine, Delbaldo, Catherine, Falandry, Claire, Norguet Monnereau, Emmanuelle, Ben Abdelghani, Meher, Smith, Denis, Rinaldi, Yves, Père Verge, Denis, Baize, Nathalie, Maillard, Emmanuel, Dohan, Anthony, Des Guetz, Gaetan, Pamoukdjian, Frédéric, Lepage, Come

Get full text

WITHDRAWN: Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease by Delbaldo, Catherine, Michiels, Stefan, Rolland, Estelle, Syz, Nathalie, Soria, Jean-Charles, Le Chevalier, Thierry, Pignon, Jean Pierre

Get full text

Combining Paclitaxel and Lapatinib as Second-line Treatment for Patients with Metastatic Transitional Cell Carcinoma: A Case Series by CULINE, Stephane, SELLAM, Zineb, BOUAITA, Linda, ASSAF, Elias, DELBALDO, Catherine, VERLINDE-CARVALHO, Muriel, POUESSEL, Damien

Get full text

Pharmacokinetic profile of cetuximab (Erbitux™) alone and in combination with irinotecan in patients with advanced EGFR-positive adenocarcinoma by Delbaldo, Catherine, Pierga, Jean-Yves, Dieras, Véronique, Faivre, Sandrine, Laurence, Valérie, Vedovato, Jean-Claude, Bonnay, Marc, Mueser, Matthias, Nolting, Arno, Kovar, Andreas, Raymond, Eric

Get full text

Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease by Delbaldo, Catherine, Michiels, Stefan, Rolland, Estelle, Syz, Nathalie, Soria, Jean-Charles, Le Chevalier, Thierry, Pignon, Jean-Pierre

Get full text

Safety of repeated administrations of ixabepilone given as a 3-hour infusion every other week in combination with irinotecan in patients with advanced malignancies by Faivre, Sandrine, Delbaldo, Catherine, Boige, Valérie, Pautier, Patricia, Soria, Jean-Charles, Namouni, Fouad, Peck, Ronald, Cohen, Marvin, Raymond, Eric

Get full text